Pharma News, 2016

The FDA has again found a lot that it doesn't like about a Chinese drugmaker.

India's Wockhardt, already trying to get out from under an FDA warning letter for two key plants, has come up short in its effort to get the agency to approve a new sterile injectables facility.

Mylan's Agila Specialties, which has already had production at three Indian plants affected by an FDA warning letter, stopped manufacturing at its Poland facility last fall after health inspectors...

18-01-2016 - http.

Scientists have flagged a smell test for Alzheimer’s disease, raising hopes that the condition can be diagnosed long before it starts to affect behaviour.

PaclitaxelResearchers have for the first time packaged the drug paclitaxel in containers derived from a patient's own immune system, protecting the drug from being destroyed by the body's own ...

One man is brain dead and three others are facing possible permanent brain damage after volunteering to take part in a drug test that went awry, French authorities said Friday.

STOCKHOLM, Sweden I January 15, 2016 I Xbrane Biopharma, a commercial phase biopharmaceutical company specialized in High Demand Complex Generics, today announced that the company has signed a sales a...

Merck has acquired IOmet, a privately-held UK-based drug discovery company focused on the development of innovative medicines for the treatment of cancer, with a particular emphasis on the fields of c...

An anti-rheumatic drug could improve the prognosis for ovarian cancer patients exhibiting a deficiency of the DNA repair protein BRCA1, a study suggests.

WASHINGTON, Jan.

PRIMA-1metResearchers from the Cancer Science Institute of Singapore (CSI Singapore) at NUS have demonstrated that an existing drug gives promising results in the treatment of colorectal cance...